MedTrace Logo

Evaluation of the CAD-det System, a Novel Non-Invasive Acoustic Diagnostic for the Diagnosis of Coronary Artery Disease

NCT03914079 · Status: SUSPENDED · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2021-01-12

No results posted yet for this study

Summary

The primary purpose of this multi-center study is to collect and study the acoustic and electrical signals created by the heart during the cardiac cycle as a result of stenosis or plaque associated with coronary artery disease (CAD).

Conditions

Sponsors & Collaborators

  • Ottawa Heart Institute Research Corporation

    collaborator OTHER

  • Horizon Health Network

    collaborator OTHER

  • University of Calgary

    collaborator OTHER

  • Hamilton Health Sciences Corporation

    collaborator OTHER

  • AusculSciences Canada Inc.

    lead INDUSTRY

Principal Investigators

  • Benjamin Chow, MD, FRCP(C) · University of Ottawa Heart Institute (UOHI)

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-05
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03914079 on ClinicalTrials.gov